Ovarian Cancer (news): The National Academies of Sciences, Engineering, and Medicine

Home - news 

 

New Report on Ovarian Cancer to Be Released March 2 Often called a silent killer because of how difficult it is to diagnose in its early stages, ovarian cancer is one of the deadliest cancers, with a five-year survival rate of just under 46 percent.  Although it is relatively uncommon, more than 21,000 women in the U.S. are diagnosed with ovarian cancer each year, and more than 14,000 die from the disease.  A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine examines current knowledge of ovarian cancer and recommends research to advance understanding in order to reduce the incidence of, and number of deaths from, ovarian cancer. In particular, the report addresses distinctions in various subtypes of ovarian cancer, challenges to early detection, the need for genetic testing, disparities in standards of care, and how to improve treatment of the disease and supportive care for its survivors. Members of the committee that conducted the study and wrote the report will present their findings and recommendations at a public briefing beginning at 11 a.m. EST on Wednesday, March 2, in the Lecture Room of the National Academy of Sciences building, 2101 Constitution Ave., N.W., Washington D.C. Those who cannot attend may view a live webcast of the event here.  Advance copies of Ovarian Cancers: Evolving Paradigms in Research and Care will be available to reporters only beginning at noon on Tuesday, March 1. The report is embargoed and not for public release before 11 a.m. EST on Wednesday, March 2. To obtain a copy of the report or register to attend the briefing, reporters should contact the Academies’ Office of News and Public Information; tel. 202-334-2138 or email news@nas.edu.